Leaflet ILOPROST ZENTIVA 20mcg / ml solution for inhalation by nebuliser

Indicated for: pulmonary arterial hypertension

Route of administration: inhalation

Substance: iloprost (antihypertensive)

ATC: B01AC11 (Blood and blood forming organs | Antithrombotic agents | Platelet aggregation inhibitors excl. heparin)

Iloprost is a synthetic analog of prostacyclin used for the treatment of pulmonary arterial hypertension and severe Raynaud's phenomenon. It works by dilating blood vessels and inhibiting platelet aggregation, improving blood flow.

The medication is administered via inhalation or intravenous infusion, as directed by a doctor. It is important to follow the treatment regimen to achieve the best results.

Side effects may include headache, dizziness, nausea, or facial flushing. In rare cases, severe hypotension or bleeding may occur.

Iloprost is not recommended for patients with hypersensitivity to this medication or conditions that increase the risk of bleeding.

General data about ILOPROST ZENTIVA 20mcg / ml

  • Substance: iloprost
  • Date of latest medicines list: 01-03-2024
  • Product code: W67925007
  • Concentration: 20mcg / ml
  • Pharmaceutical form: solution for inhalation by nebuliser
  • Quantity: 168
  • Product type: Generic medicine
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

  • Manufacturer: ZENTIVA, K.S - REPUBLICA CEHA
  • Holder: ZENTIVA K.S. - REPUBLICA CEHA
  • Number: 14041/2021/07
  • Shelf life: 4 years

Concentrations available for iloprost

  • 10mcg/ml
  • 20mcg/ml